P

Precipio
D

PRPO

11.060
USD
0.19
(1.75%)
مغلق
حجم التداول
2
الربح لكل سهم
0
العائد الربحي
-
P/E
-5
حجم السوق
16,722,842
أصول ذات صلة
B
BNGO
-0.04000
(-1.12%)
3.53000 USD
E
EXAS
-0.260
(-0.49%)
53.270 USD
F
FATE
-0.04000
(-3.15%)
1.23000 USD
NTRA
NTRA
2.910
(1.76%)
168.210 USD
R
RDHL
0.02000
(1.14%)
1.78000 USD
V
VCYT
0.210
(0.79%)
26.640 USD
المزيد
الأخبار المقالات

العنوان: Precipio

القطاع: Healthcare
الصناعة: Diagnostics & Research
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.